A type of drug already used to treat obesity and Type 2 diabetes, when taken six months prior to the diagnosis of COVID-19, was associated with a decreased risk of hospitalization, respiratory complications and death in COVID-19 patients with Type 2 diabetes, according to researchers.
from Top Health News -- ScienceDaily https://ift.tt/3uipBbh
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
Solar cells made of perovskite hold much promise for the future of solar energy. However, the material degrades quickly, severely limiting i...
-
With 73,642 new daily recoveries, the most so far, India's recovery rate has improved to 77.32%, while death rate has come down to 1.72%...
-
Although organ failure can be fatal, your kidneys, heart, and liver are prepared for this catastrophe. Emerging research supports the findin...
No comments:
Post a Comment